NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CuroNZ Limited

CuroNZ Limited

Private
New ZealandHealthcare & Life Scienceshttps://curonz.com/

Last Round

Grant

Dec 11, 2015

Total Funding Raised

$960,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CuroNZ Limited is a clinical-stage biotechnology company that develops a platform of peptide drugs for the treatment of severe neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologypeptide therapeuticsCNS disordersepilepsy treatmentneuroprotectiondrug discoveryclinical trialsblood-brain barrierneuroregenerationbiotech startupdrug out-licensingcentral nervous systemCNSbiotech pipelinepharma partnering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CuroNZ Limited Comps

Public and private peers based on sector, stage, and business model.

CuroNZ Limited comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CuroNZ Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 11, 2015
GrantOct 14, 2013
DebtJul 8, 2011
AngelMay 1, 2010
SeedDec 18, 2009

CuroNZ Limited Investors

Notable investors and investment history

CuroNZ Limited investors
InvestorRounds
Callaghan InnovationGrant
National MS SocietyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 361% MoM, reaching 6.8K.

  • May 1, 2010

    Completed an Angel funding round.

CuroNZ Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CuroNZ Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CuroNZ Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Zealand
Employee Range3
Year Founded2009
Last FundingDec 11, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.